The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life

Archives of Internal Medicine

Volumn 156, Issue 16, 1996, Pages 1829-1836

  Gage, Brian F ^a,d   Cardinalli, Andria B ^b   Owens, Douglas K ^b,c  

^a WASHINGTON UNIVERSITY   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PRIORITY JOURNAL; QUALITY OF LIFE; STROKE;

AGED; ANTICOAGULANTS; ASPIRIN; CEREBROVASCULAR DISORDERS; FEMALE; HEALTH STATUS; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; WARFARIN;

EID: 0029840614     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.16.1829     Document Type: Article

References (46)

1. Dennis MS, Burn JPS, Sandercock PAG, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24:796-800.
2. Nydevik I, Eller B, Larsen L, Milton A, Wall B, Hulter-Asberg K. Functional status of stroke patients in long-term care. Scand J Caring Sci. 1993;7:85-91.
3. Bamford JM, Sandercock PAG, Warlow CP, Slattery J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1989;20:82B.
4. Ware JE, Sherbourne CD, The MOS 35-item Short-Form Health Survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473-483.
5. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40:593-600.
6. Wolfson AD, Sinclair A, Bombardier C, McGeer A. Preference measurements for functional status in stroke patients: interrater and intertechnique comparisons. In: Kane RL, Kane RA, eds. Values in Long Term Care. Toronto, Ontario: DC Heath & Co; 1982:191-214.
7. Nease RF Jr, Kneeland T, O'Connor GT, et al, for the Ischemic Heart Disease Patient Outcomes Research Team. Variation in patient utilities for outcomes of the management of chronic stable angina: implications for clinical practice guidelines. JAMA 1995;273:1185-1190.
8. Tsevat J, Cook EF, Green ML, et al. Health values of the seriously ill. Ann Intern Med. 1995;122:514-520.
9. Owens DK, Sox HC. Medical decision making: probabilistic medical reasoning. In: Shortliffe EH, Perreault LE, Fagan LM, Wiederhold G, eds. Medical Informatics: Computer Applications in Medicine. Reading, Mass: Addison-Wesley Publishing Co; 1990:70-116.
10. Niemi M, Laaksonen R, Kotila M, Waltimo O. Quality of life 4 years after stroke. Stroke. 1988;19:1101-1107.
11. Lancaster TR, Singer DE, Sheehan MA, et al. The impact of long-term warfarin therapy on quality of life: evidence from a randomized trial. Arch Intern Med. 1991;151:1944-1949.
12. de Haan RJ, Limburg M, Van der Meulen JH, Jacobs HM, Aaronson NK. Quality of life after stroke: impact of stroke type and lesion location. Stroke. 1995; 26:402-408.
13. de Haan R, Aaronson N, Limburg M, Hewer RL, van Crevel H. Measuring quality of life in stroke. Stroke. 1993;24:320-327.
14. Solomon NA, Slick HA, Russo CJ, Lee J, Schulman KA. Patient preferences for stroke outcomes. Stroke. 1994;25:1721-1725.
15. Ahlsio B, Britton M, Murray V, Theorell T. Disablement and quality of life after stroke. Stroke. 1984;15:886-890.
16. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993; 13:89-102.
17. Sumner W, Nease R, Littenberg B. U-Trter: a utility assessment tool. Presented at the 15th Annual Symposium on Computer Applications in Medical Care; November 1991; Washington, DC.
18. Patrick DL, Starks HE, Cain KC, Uhlmann RF, Pearlman RA. Measuring preferences for health states worse than death. Med Decis Making. 1994;14:9-18.
19. Torrance GW. Social preferences for health states: an empirical evaluation of three measurement techniques. Socioecon Plann Sci. 1976;10:129-136.
20. Beck JR, Kassirer JP, Pauker SG. A convenient approximation of life expectancy (the 'D.E.A.L.E.'), II: use in medical decision-making. Am J Med. 1982; 73:889-897.
21. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet. 1987;1:526-529.
22. Deyo RA, Diehr P, Patrick DL, Reproducibility and responsiveness of health status measures. Control Clin Trials. 1991;12:142S-158S.
23. Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76:378-382.
24. Nease RF, Owens DK. A method for estimating the cost-effectiveness of incorporating patient preferences into practice guidelines. Med Decis Making. 1994;14:382-392.
25. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med. 1981; 305:982-987.
26. Sanders GD, Owens DK, Padian N, Cardinalli AB, Sullivan AN, Nease RF. A computer-based interview to identify HIV risk behaviors and to assess patient preferences for HIV-related health states. In: Proceedings of the 18th Annual Symposium on Computer Applications in Medical Care. Washington, DC: American Medical Informatics Association; 1994;1:20-24.
27. Owens D, Nease R. Physician beliefs about occupational risk and severity of health states associated with HIV and hepatitis infection. In: Proceedings and Abstracts of the Sixth International Conference on AIDS. San Francisco: University of California; 1990;3:308.
28. O'Meara JJ, McNutt RA, Evans AT, Moore SW, Downs SM. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med. 1994;330:1864-1869.
29. Hirsch J. Influence of low-intensity warfarin treatment on patients' perceptions of quality of life. Arch Intern Med. 1991;151:1921-1922.
30. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett ELC. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med. 1995;155:277-281.
31. Naglie G, Detsky AS. Treatment of chronic nonvalvular atrial fibrillation in the elderly: a decision analysis. Med Decis Making. 1992;12:239-249.
32. Gage BF, Cardinalli AB, Albers GW, Owens DK. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA. 1995;274:1839-1845.
33. Eckman MH, Levine HJ, Pauker SG. Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues. Chest. 1995;108(suppl):457-470.
34. Beck JR, Pauker SG. Anticoagulation and atrial fibrillation in the bradycardiatachycardia syndrome. Med Decis Making. 1981;1:284-301.
35. Laupacis A, Albers GW, Dalen JE, Dunn MI, Feinberg W, Jacobson AK. Antithrombotic therapy in atrial fibrillation. Chest. 1995;108(suppl):352-359.
36. Matchar DB, McCrory DC, Barnett HJM, Feussner JR. Medical treatment for stroke prevention. Ann Intern Med. 1994;121:41-53.
37. Flegel KM, Hutchinson TA, Groome PA, Tousignant P. Factors relevant to preventing embolic stroke in patients with non-rheumatic atrial fibrillation. J Clin Epidemiol. 1991;44:551-560.
38. Nadeau SE. The use of expected value as an aid to decisions regarding anticoagulation in patients with atrial fibrillation. Stroke. 1993;24:2128-2134.
39. Caro JJ, Groome PA, Flegel KM. Atrial fibrillation and anticoagulation: from randomised trials to practice. Lancet. 1993;341:1381-1384.
40. Disch DL, Greenberg ML, Holzberger PT, Malenka DJ, Birkmeyer JD. Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Ann Intern Med. 1994;120:449-457.
41. Lane D, Hutchinson T. The notion of 'acceptable risk': the role of utility in drug management. J Chronic Dis. 1987;40:621-625.
42. Man-Son-Hing M, Laupacis A, O'Connor A, et al. Warfarin for atrial fibrillation: the patient's perspective. Arch Intern Med. 1996;156:1841-1848.
43. Christensen-Szalanski J. Discount functions and the measurement of patients' values: women's decisions during childbirth. Med Decis Making. 1984;4:47.
44. Llewellyn-Thomas HA, Sutherland HJ, Thiel EC. Do patients' evaluations of a future health state change when they actually enter that state? Med Care. 1993; 11:1002-1012.
45. Sutherland HJ. Assessing patients' preferences. Med Decis Making. 1995;15: 286-287.
46. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Disabil. 1978;31:697-704.